Inspire Medical Systems Inc. (INSP) has issued a recall of its Inspire IV Implantable Pulse Generator (IPG) Model 3028 due to a critical manufacturing defect. The FDA has classified this as the most ...

DUBLIN--(BUSINESS WIRE)--The "Implantable Pulse Generator Market - Forecasts from 2019 to 2024" report has been added to ResearchAndMarkets.com's offering. Implantable pulse generator market is ...

CARLSBAD, Calif.--(BUSINESS WIRE)--Nalu Medical Inc. (“Nalu”) revealed significant findings from a landmark clinical trial evaluating the Nalu Peripheral Nerve Stimulation (PNS) System utilizing their ...

VisCardia will soon be enrolling almost 300 patients in a clinical trial.

We are determining the anatomical characteristics, simulation, design and test development of an Implantable Pulse Generator (IPG). Our project goal is to determine the lead pathway for the electrode ...

Onward Medical NV reported initial patient enrollment in its Hemon early feasibility study and first-in-human trial of its ARC implantable pulse generator. The study will examine stabilization of ...

Impulse Dynamics announced that a two-lead version of its implantable pulse generator to deliver cardiac contractility modulation therapy to patients with HF has been approved by the FDA. The ...

Onward Medical announced today that it launched a capital increase by way of a bockbuild offering through a private placement ...

Continued strong sales and profit growth in 3Q25 ~~ Updating 2025 sales and profit outlook; providing preliminary outlooks ...

Nalu Medical, which is commercializing a nerve stimulation implant for chronic neuropathic pain, filed on Friday with the SEC to raise up to $100 million. Nalu states that its miniaturized implantable ...

Psychiatrists at Rush University Medical Center are the first in Chicago to use a vagus nerve stimulator (VNS), an implantable, pacemaker-like device, as a therapy to treat long-term, ...